Literature DB >> 10611676

Opportunities at the interface of chemistry and biology.

A B Martin1, P G Schultz.   

Abstract

The combination of the tools and principles of chemistry, together with the tools of modern molecular biology, allow us to create complex synthetic and natural molecules, and processes with novel biological, chemical and physical properties. This article illustrates the tremendous opportunity that lies at this interface of chemistry and biology by describing a number of examples, ranging from efforts to expand the genetic code of living organisms to the use of combinatorial methods to generate biologically active synthetic molecules.

Mesh:

Substances:

Year:  1999        PMID: 10611676

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  10 in total

Review 1.  Beyond the canonical 20 amino acids: expanding the genetic lexicon.

Authors:  Travis S Young; Peter G Schultz
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

2.  Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Visilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 3.  Designing logical codon reassignment - Expanding the chemistry in biology.

Authors:  Anaëlle Dumas; Lukas Lercher; Christopher D Spicer; Benjamin G Davis
Journal:  Chem Sci       Date:  2014-07-14       Impact factor: 9.825

4.  Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergei V Sennikov; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2017-08-05       Impact factor: 5.310

5.  Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA-Histone complexes.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergey E Sedykh; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2018-09-28       Impact factor: 5.310

6.  Increase in Autoantibodies-Abzymes with Peroxidase and Oxidoreductase Activities in Experimental Autoimmune Encephalomyelitis Mice during the Development of EAE Pathology.

Authors:  Anna S Tolmacheva; Kseniya S Aulova; Andrey E Urusov; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  Molecules       Date:  2021-04-04       Impact factor: 4.411

Review 7.  Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans.

Authors:  Anna S Tolmacheva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

8.  Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Taisiya A Parkhomenko; Vasilii B Doronin; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

9.  Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Edward Cesnik; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Alexey Korablev; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaja; Sergei V Sennikov; Valentina N Buneva; Thomas Budde; Sven G Meuth; Irina A Orlovskaya; Nelly A Popova; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2015-10-23       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.